The Almond Yogurt Study (AYS) (AYS)
The Impact of Almond Food Structure in a Standardized Yogurt Breakfast Meal on Gastric Emptying, Oral Processing Behaviours, Appetite-Regulating Hormones, Postprandial Metabolism, and Subjective Satiety: A Randomized Crossover Trial
The goal of this clinical trial is to explore how almond food structure influences gastric emptying rates when consumed by healthy adult women as part of a standardized breakfast meal. The main questions it aims to answer are:
- Does the structure of almonds (whole, chopped, buttered) influence gastric emptying ?
- What is the correlation between chewing behaviour, gastric emptying, and changes in postprandial triacylglycerols and satiety (hormones and ratings) within the context of an increasingly disrupted nut matrix.
A tanulmány áttekintése
Állapot
Állapot
Körülmények
Körülmények
Beavatkozás / kezelés
Beavatkozás / kezelés
Részletes leírás
This study is investigating how the structure of almonds (whole, chopped, buttered) as part of a yogurt-based breakfast meal influences gastric emptying and postprandial metabolism. Over three randomized visits, fasted healthy adult female participants will arrive at the research centre where an iv-catheter will be inserted for serial blood sampling over 6 hours for analysis of plasma triacylglycerols, GLP-1, CCK, glucose, and insulin. Participants will consume each meal while being video recorded to quantify chewing frequency and eating time. Paper questionnaires will periodically assess participants' eating experiences and hunger sensations throughout the visit (e.g., exertion, liking, hunger, fullness). Gastric ultrasonography will be used to visualize and quantify the cross-sectional area of the gastric antrum so that changes in gastric volume can be tracked over time. Overall, this study aims to determine how almond form, as an example of food structure, influences chewing, gastric emptying, satiety and postprandial metabolism.
Tanulmány típusa
Tanulmány típusa
Beiratkozás (Becsült)
Beiratkozás
Fázis
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi kapcsolat
Tanulmányi kapcsolat
- Név: Amanda J Wright, PhD
- Telefonszám: 54697 519-824-4120
- E-mail: ajwright@uoguelph.ca
Tanulmányi helyek
-
-
Ontario
-
Guelph, Ontario, Kanada, N1G 2G4
- Department of Human Health Sciences
-
Kapcsolatba lépni:
- Amanda J Wright, PhD
- Telefonszám: 54697 5190824-4120
- E-mail: ajwright@uoguelph.ca
-
Kapcsolatba lépni:
- Alison M Duncan, PhD
-
Kutatásvezető:
- Amanda J Wright, PhD
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Healthy female adults aged 18-45 years.
- Body Mass Index (BMI) between 18.5-27.9 kg/m2, or waist circumference of less than 88 cm
- Visible gastric antrum on ultrasound
- No known food allergies or sensitivities
- Non restrained eaters (TFEQ, see below)
- No history of gastrointestinal diseases that may interfere with eating behavior or digestion
- Not on medications that affect appetite (including GLP-1 agonists), digestion, blood sugar regulation, saliva production, or chewing
- Stable medication use
- Non-smokers
- Not gained or lost significant weight during the past 3 months
- Regular monthly menstrual cycles
- Not pregnant, lactating or post-menopausal
Exclusion Criteria:
- Diabetes or other metabolic disorders affecting glycemia and overall cardiometabolic health
- Blood pressure > 140/90 mm Hg
- Any food allergies, intolerances, or sensitivities
- Pregnant or breastfeeding
- Participation in another clinical trial
- Excessive alcohol consumption (more than 14 drinks per week)
- Smokers or those with a smoking history of more than 10 years
- Regular use of recreational drugs (e.g., marijuana, ecstasy, LSD, magic mushrooms, etc.)
- Restrained eater (>16) as defined by the questionnaire at screening (Three-Factor Eating Questionnaire, Stunkard et al., 1985)
- Unusual sleep patterns
- Irregular breakfast consumption
- Recent weight changes, or intended weight loss or gain; lost/gained 10% of body weight within the last 6 months
- Food allergies/sensitivities or any life-threatening allergies
- Using medications known to affect appetite, digestion, blood sugar regulation, or chewing/swallowing (excluding oral contraceptives).
- Experiences dry mouth in general or due to medication side effects
- Inability to adhere to study protocols
- Not comfortable providing IV-line blood samples
- Not comfortable providing ultrasound scans
- Not comfortable being video recorded while eating
- Avoids consuming almonds/yogurt in general
- Avoids eating hard foods to prevent dental fractures
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Alapvető tudomány
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Crossover kiosztás
- Maszkolás: Kettős
Fegyverek száma
Fegyverek és beavatkozások
Résztvevő csoport / karRésztvevő csoport / kar |
Beavatkozás / kezelésBeavatkozás / kezelés |
|---|---|
|
Kísérleti: Whole - Chopped - Buttered
Participants consume 115 g vanilla yogurt with 60 g whole almonds at the first intervention visit, chopped almonds at the second intervention visit, and almonds processed into almond butter at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Kísérleti: Whole - Buttered - Chopped
Participants consume 115 g vanilla yogurt with 60 g whole almonds at the first intervention visit, buttered almonds at the second intervention visit, and chopped almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Kísérleti: Buttered - Whole - Chopped
Participants consume 115 g vanilla yogurt with 60 g buttered almonds at the first intervention visit, whole almonds at the second intervention visit, and chopped almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Kísérleti: Buttered - Chopped - Whole
Participants consume 115 g vanilla yogurt with 60 g buttered almonds at the first intervention visit, chopped almonds at the second intervention visit, and whole almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Kísérleti: Chopped - Buttered - Whole
Participants consume 115 g vanilla yogurt with 60 g chopped almonds at the first intervention visit, buttered almonds at the second intervention visit, and whole almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Kísérleti: Chopped - Whole - Buttered
Participants consume 115 g vanilla yogurt with 60 g chopped almonds at the first intervention visit, whole almonds at the second intervention visit, and buttered almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Gastric emptying half-time
Időkeret: At each study visit, based on assessments at 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated from ultrasound imaging of the gastric antrum cross-sectional area at baseline (fasted) and after consumption of the breakfast meal, in minutes |
At each study visit, based on assessments at 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Másodlagos eredményintézkedések
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Eating time
Időkeret: From 0 minutes until the end of eating the breakfast meal
|
The time to consume the breakfast meal based on video recordings, in minutes |
From 0 minutes until the end of eating the breakfast meal
|
|
Changes from baseline in postprandial satiety visual analogue scale ratings
Időkeret: 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Paper questionnaire scale ratings (in mm) of Hunger, Fullness, Prospective Consumption, and Desire to Eat where each is 100 mm ranging from 0 (minimum) to 100 (maximum). For example, 0 = Not at all Hungry and 100 = As Hungry as Possible. |
0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma triacylglycerol concentration
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in mmol/L |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Triacylglycerol response - incremental area under the curve (AUC)
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma GLP-1 concentration
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in pg/mL |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
GLP-1 response - incremental area under the curve (AUC)
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma CCK concentration
Időkeret: 0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in pmol/L |
0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
CCK response - incremental area under the curve (AUC)
Időkeret: 0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in gastric volume
Időkeret: 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on ultrasound imaging of the gastric antrum cross-sectional area at baseline (fasted) and after eating the breakfast meal, in mL |
0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Gastric volume - incremental area under the curve (AUC)
Időkeret: 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on ultrasound imaging of the gastric antrum cross-sectional area at baseline (fasted) and after eating the breakfast meal |
0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Egyéb eredményintézkedések
Egyéb eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Borg rating of perceived exertion
Időkeret: Immediately after the breakfast meal is consumed
|
Participant paper scale rating of effort required to chew the breakfast meal where 0 = No effort at all and 10 = Very very severe chewing effort |
Immediately after the breakfast meal is consumed
|
|
Changes from baseline in plasma blood glucose concentration
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in mmol/mL |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Glucose response - incremental area under the curve (AUC)
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma blood insulin concentration
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in pmol/mL |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Insulin response - Area under the curve (AUC)
Időkeret: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Product liking and perceived attributes
Időkeret: Immediately after eating the breakfast meal
|
Participant paper scale questionnaire ratings |
Immediately after eating the breakfast meal
|
|
Eating rate
Időkeret: From 0 minutes until the end of eating the breakfast meal
|
Calculated from video recordings of eating session, combining meal portion consumed (in grams) and eating time (minutes), grams/minute |
From 0 minutes until the end of eating the breakfast meal
|
|
Number of chews
Időkeret: From 0 minutes until the end of eating the breakfast meal
|
Determined by count from video recordings of each eating session |
From 0 minutes until the end of eating the breakfast meal
|
Együttműködők és nyomozók
Szponzor
Szponzor
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Becsült)
Tanulmány kezdete
Elsődleges befejezés (Becsült)
Elsődleges befejezés
A tanulmány befejezése (Becsült)
A tanulmány befejezése
Tanulmányi regisztráció dátumai
Először benyújtva
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Első közzététel
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Utolsó frissítés közzétéve
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
Egyéb vizsgálati azonosító számok
- ID3014
- 400819 (Egyéb támogatási/finanszírozási szám: Natural Sciences & Engineering Research Council of Canada)
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
IPD terv leírása
Although we are not required to make this data available, we are currently working to understand how to do this in a safe way, as per our institutional guidelines. As we learn more, we may pursue this. We are obtaining consent from study participants for this option.
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .